[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,161,461
  • Shares Outstanding, K 32,434
  • Annual Sales, $ 780,570 K
  • Annual Income, $ 62,870 K
  • EBIT $ 189 M
  • EBITDA $ 414 M
  • 60-Month Beta 0.76
  • Price/Sales 1.57
  • Price/Cash Flow 2.48
  • Price/Book 3.92

Options Overview Details

View History
  • Implied Volatility 52.73% (-1.21%)
  • Historical Volatility 45.37%
  • IV Percentile 36%
  • IV Rank 35.46%
  • IV High 88.16% on 03/11/26
  • IV Low 33.26% on 08/18/25
  • Expected Move (DTE 3) 2.42 (6.79%)
  • Put/Call Vol Ratio 82.80
  • Today's Volume 419
  • Volume Avg (30-Day) 145
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 1,915
  • Open Int (30-Day) 853
  • Expected Range 33.27 to 38.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.53
  • Number of Estimates 2
  • High Estimate $1.58
  • Low Estimate $1.48
  • Prior Year $1.47
  • Growth Rate Est. (year over year) +4.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.87 +11.98%
on 04/24/26
40.50 -11.88%
on 05/08/26
+0.22 (+0.62%)
since 04/10/26
3-Month
31.54 +13.16%
on 04/06/26
46.66 -23.51%
on 02/17/26
-9.59 (-21.18%)
since 02/12/26
52-Week
28.34 +25.94%
on 05/23/25
50.79 -29.73%
on 12/29/25
+6.13 (+20.74%)
since 05/12/25

Most Recent Stories

More News
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio – – Extends Collegium’s Long-Term Revenue Outlook; AZSTARYS...

COLL : 35.69 (-0.34%)
1 Healthcare Stock with Competitive Advantages and 2 We Brush Off

1 Healthcare Stock with Competitive Advantages and 2 We Brush Off

COLL : 35.69 (-0.34%)
GMED : 76.13 (-0.72%)
PRVA : 23.01 (+1.10%)
COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results

COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results

COLL : 35.69 (-0.34%)
Collegium Pharmaceutical Q1 Earnings Call Highlights

Collegium Pharmaceutical (NASDAQ:COLL) reported first-quarter 2026 results highlighting continued growth in its ADHD franchise led by JORNAY PM, steady performance from its pain portfolio, and progress...

COLL : 35.69 (-0.34%)
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 CY2026 Expectations, Stock Soars

Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 CY2026 Expectations, Stock Soars

COLL : 35.69 (-0.34%)
Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL : 35.69 (-0.34%)
Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

– Generated Quarterly Net Revenues of $193.5 Million, Up 9% Year-over-Year –  – Generated JORNAY PM ® Quarterly Net Revenue of $38.9 Million, Up 36% Year-over-Year – – On Track...

COLL : 35.69 (-0.34%)
Collegium Pharmaceutical (COLL) Q1 Earnings Report Preview: What To Look For

Collegium Pharmaceutical (COLL) Q1 Earnings Report Preview: What To Look For

COLL : 35.69 (-0.34%)
1 Small-Cap Stock on Our Watchlist and 2 We Question

1 Small-Cap Stock on Our Watchlist and 2 We Question

TTEK : 28.71 (-2.97%)
COLL : 35.69 (-0.34%)
M : 18.52 (-0.91%)
3 Reasons to Sell COLL and 1 Stock to Buy Instead

3 Reasons to Sell COLL and 1 Stock to Buy Instead

COLL : 35.69 (-0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 38.20
2nd Resistance Point 37.31
1st Resistance Point 36.50
Last Price 35.69
1st Support Level 34.80
2nd Support Level 33.91
3rd Support Level 33.10

See More

52-Week High 50.79
Fibonacci 61.8% 42.21
Fibonacci 50% 39.56
Fibonacci 38.2% 36.91
Last Price 35.69
52-Week Low 28.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.